Another breakthrough in Cancer treatment
A large scale clinical trial performed at the institute for research in immunology and cancer located in Montreol, Canada, has acheive improved results at treating Cancer patients with Ribavirin – a common anti-viral drug. The new treatment can be useful in 30% of Cancer diseases include the most common ones.
Read the full story (ScienceDaily)
